Similar articles

• Pharmacological prevention of post-ERCP pancreatitis--an everlasting dream?

  Hellmig S, Fölsch UR. Hellmig S, et al. Dig Liver Dis. 2006 Aug;38(8):596-8. doi: 10.1016/j.dld.2006.04.005. Epub 2006 May 30. Dig Liver Dis. 2006. PMID: 16731061 No abstract available.
• Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.

  Testoni PA, Mariani A, Masci E, Curioni S. Testoni PA, et al. Dig Liver Dis. 2006 Aug;38(8):588-95. doi: 10.1016/j.dld.2006.04.001. Epub 2006 May 30. Dig Liver Dis. 2006. PMID: 16731060
• Prophylaxis of post-ERCP pancreatic complications with gabexate.

  Piscaglia F, Righini R, Tewelde AG. Piscaglia F, et al. Dig Liver Dis. 2007 Mar;39(3):291; author reply 291. doi: 10.1016/j.dld.2006.12.011. Epub 2007 Jan 30. Dig Liver Dis. 2007. PMID: 17267312 No abstract available.
• [Can post-ERCP acute pancreatitis be predicted and prevented?].

  Heyries L. Heyries L. Gastroenterol Clin Biol. 2001 Jan;25(1 Suppl):1S241-6. Gastroenterol Clin Biol. 2001. PMID: 11223596 Review. French. No abstract available.
• Antiproteases in preventing post-ERCP acute pancreatitis.

  Tsujino T, Kawabe T, Omata M. Tsujino T, et al. JOP. 2007 Jul 9;8(4 Suppl):509-17. JOP. 2007. PMID: 17625308 Review.